Re-stenosis of a sirolimus-coated stent in a heart transplant recipient with allograft vasculopathy

Journal of Heart and Lung Transplantation

Volumn 24, Issue 9, 2005, Pages 1444.e9-1444.e11

  Aqel, Raed ^a,b   Gupta, Ritesh ^a   Tallaj, Jose A ^a,b   Zoghbi, Gilbert J ^a,b  

^a University of Alabama at Birmingham   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN;

ADULT; ARTICLE; CASE REPORT; DRUG ELUTING STENT; DYSPNEA; HEALTH SURVEY; HEART CATHETERIZATION; HEART TRANSPLANTATION; HUMAN; MALE; PRIORITY JOURNAL; SURVIVAL; VASCULAR DISEASE;

EID: 24344476068     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2004.11.315     Document Type: Article

References (24)

1. M.T. Grattan, C.E. Moreno-Cabral, V.A. Starnes Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis JAMA 261 1989 3561 3566
2. B.M. Keck, L.E. Bennett, J. Rosendale Worldwide thoracic organ transplantation a report from the UNOS/ISHLT International Registry for Thoracic Organ Transplantation Clin Transplant 1999 35 49
3. J.D. Hosenpud, G.D. Shipley, C.R. Wagner Cardiac allograft vasculopathy current concepts, recent developments, and future directions J Heart Lung Transplant 11 1992 9 23
4. M.R. Mehra, P.A. Uber, H.O. Ventura, R.L. Scott, M.H. Park The impact of mode of donor brain death on cardiac allograft vasculopathy an intravascular ultrasound study JAMA 43 2004 806 810
5. M.R. Mehra, H.O. Ventura, D.D. Stapleton Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac allograft vasculopathy J Heart Lung Transplant 14 1995 632 639
6. J. Young Allograft vasculopathy Circulation 100 1999 458 460
7. M.S. Kemna, H.A. Valantine, S.A. Hunt Metabolic risk factors for atherosclerosis in heart transplant recipients Am Heart J 128 1994 68 72
8. P. Gallo, L. Agozzino, A. Angelini Causes of late failure after heart transplantation a ten-year survey J Heart Lung Transplant 16 1997 1113 1121
9. A.A. Halle III, G. DiSciascio, E.K. Massin Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients JAMA 26 1995 120 128
10. U. Sigwart, J. Puel, V. Mirkovitch, F. Joffre, L. Kappenberger Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty N Engl J Med 316 1987 701 706
11. P.M. Wong, C. Piamsomboon, A. Mathur Efficacy of coronary stenting in the management of cardiac allograft vasculopathy Am J Cardiol 82 1998 239 241
12. M. Redonnet, C. Tron, R. Koning Coronary angioplasty and stenting in cardiac allograft vasculopathy following heart transplantation Transplant Proc 32 2000 463 465
13. B. Hublein, K. Pethig, C. Maass, T. Wahlers, A. Haverich Coronary artery stenting in cardiac allograft vascular disease Am Heart J 134 1997 930 938
14. S.P. Jain, S.R. Ramee, C.J. White Coronary stenting in cardiac allograft vasculopathy JAMA 32 1998 1636 1640
15. J.M. Aranda, D.F. Pauly, R.A. Kerensky Percutaneous coronary intervention versus medical therapy for coronary allograft vasculopathy. One center's experience J Heart Lung Transplant 21 2002 860 866
16. V. Klauss, H. Stempfle, K. Theisen Vascular brachytherapy for treatment of cardiac allograft vasculopathy J Heart Lung Transplant 20 2001 792 794
17. G.J. Zoghbi, V.K. Misra, G.D. Chapman Long-term follow-up of brachytherapy for treatment of allograft in-stent restenosis Cathet Cardiovasc Interv 61 2004 217 221
18. M.C. Morice, P.W. Serruys, J.E. Sousa RAVEL study group Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 2002 1773 1780
19. J.W. Moses, M.B. Leon, J.J. Popma SIRIUS investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
20. D. Behrendt, P. Ganz, J.C. Fang Cardiac allograft vasculopathy Curr Opin Cardiol 15 2000 422 429
21. D.E. Johnson, S.Z. Gao, J.S. Schroeder, W.M. DeCampli, M.E. Billingham The spectrum of coronary artery pathologic findings in human cardiac allografts J Heart Transplant 8 1989 349 359
22. D. Mancini, S. Pinney, D. Burkhoff Use of rapamycin slows progression of cardiac transplantation vasculopathy Circulation 108 2003 48 53
23. R. Gallo, A. Padurean, T. Jayaraman Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle Circulation 99 1999 2164 2170
24. P.N. Ruygrok, B. Webber, S. Faddy Angiographic regression of cardiac allograft vasculopathy after introducing sirolimus immunosuppression J Heart Lung Transplant 22 2003 1276 1279